GTR 108864685
Bids Are Invited For The Purpose Of This Term Of Reference Is The Acquisition Of Oncological Medications, To Be Used By The Belém Aeronautical Hospital And Other Organizations Supported By The Belém Support Group (Gapbe), In Accordance With The Conditions, Quantities And Requirements Established In This Instrument.
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
108864685
Tendering Authority
Subscribe to view
Tender No
90126/2025
Financer Name
Self-Funded
Work Title
Bids Are Invited For The Purpose Of This Term Of Reference Is The Acquisition Of Oncological Medications, To Be Used By The Belém Aeronautical Hospital And Other Organizations Supported By The Belém Support Group (Gapbe), In Accordance With The Conditions, Quantities And Requirements Established In This Instrument.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
27-02-2026
Closed
Work Detail
The Purpose Of This Term Of Reference Is The Acquisition Of Oncological Medications, To Be Used By The Belém Aeronautical Hospital And Other Organizations Supported By The Belém Support Group (Gapbe), In Accordance With The Conditions, Quantities And Requirements Established In This Instrument.. Abemaciclib,Abiraterone Acetate,Acid Zoledronic,Adalimumab,Aflibercept,Aflibercept,Epoetin Alfa,Epoetin Alfa,Anastrozole,Bevacizumab,Bevacizumab,Bicalutamide,Bortezomib,Cape Citabine,Carboplatin,Cetuximab,Cyclophosphamide,Cyclophosphamide,Cisplatin,Daratumumab,Denosumab,Denosumab,Docetaxel,Docetaxel,Doxorubicin Hydrochloride, Doxorubicin Hydrochloride, Enzalutamide, Epirubicin Hydrochloride, Etoposide, Filgrastim, Fluorouracil, Calcium Folinate, Fulvestrant, Gefitinib, Gemcitabine Hydrochloride, Gemcitabine Hydrochloride, Goserelin Acetate, Goserelin Acetate, Hydroxyurea, Imatinib Mesylate, Imatinib Mesylate, Irinotecan Hydrochloride, Lenalidomide, Letrozole, Leuprorelin Acetate, Leuprorelin Acetate,Lorlatinib,Mesna,Methotrexate,Methotrexate,Nivolumab,Nivolumab,Octreotide,Octreotide,Octreotide,Olaparib,Osimertinib,Oxaliplatin,Oxaliplatin,Paclitaxel,Pembrolizumab,Pemetrexed,Pertuzumab,Ranibizumab,Sorafenib Tosylate,Sunitinib,Sunitinib,Sunitinib,Talquetamab,Tamoxifen Citrate, Temozolomide, Temozolomide, Temozolomide, Tocilizumab, Trastuzumab, Trastuzumab, Abemaciclib, Adalimumab, Aflibercept, Aflibercept, Epoetin Alpha, Cetuximab, Daratumumab, Denosumab, Enzalutamide, Fluorouracil, Calcium Folinate, Goserelin Acetate,Lenalidomide,Leuprorelin Acetate,Lorlatinib,Nivolumab,Nivolumab,Octreotide,Octreotide,Olaparib,Osimertinib,Paclitaxel,Pembrolizumab,Pertuzumab
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
ef09ca5c-269d-452a-aee2-bc3c4f5c6a99.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.